Determination of Anxiety, Anxiety Level and Quality of Life of Heart Failure Patients in the COVID-19 Process


Abstract views: 120 / PDF downloads: 85

Authors

  • Ayfer HİÇERİMEZ Fatih Sultan Mehmet EAH
  • Asibe ÖZKAN
  • Semra AĞUSTOS
  • Nurdan SAYGILI ERİŞİR

DOI:

https://doi.org/10.5281/zenodo.7919355

Keywords:

Anxiety, Heart Failure, Quality of Life

Abstract

Purpose: This study was planned as a cross-sectional, descriptive and correlational study to determine the relationship between the level of worry and anxiety experienced by patients with heart failure during COVID-19 and quality of life. 

Material-Methods: The study data were collected between July and October 2020 by means of a patient identification form and the Worry and Anxiety Scale and the Minessota Quality of Life with Heart Failure scale, which were completed by face-to-face interview method. Our sample consisted of 132 patients who volunteered to participate in the study and met the inclusion criteria and were admitted to the heart failure outpatient clinic of  Dr. Siyami Ersek  Chest and Cardiovascular Surgery Training and Research Hospital.   Data were analyzed using SPSS 22.0 software.

Results: The mean age of the patients was 53.30±10.45 years and 57.6% were female. 51.5% were diagnosed with heart failure 13-24 months ago, 69.7% were NYHA II according to the New York Heart Association (NYHA) classification, 72.7% needed psychological support during the pandemic, but only 18.2% received psychological support. When the scores obtained from the Worry and Anxiety Scale (WAS) and the Minnesota Living with Heart Failure Questionnaire were compared according to gender, education and income status, it was observed that the WAS scores were higher at a level of statistical significance and the quality of life scores were lower at a level of significance in women, primary school graduates and those with low income (p<0.05).  It was found that the worry and anxiety levels of patients with a shorter time to diagnosis were higher at a level of statistical significance, and in patients with a high NYHA rating, the physical function sub-dimension score of the Minnesota Living with Heart Failure Questionnaire and the low score obtained in total were statistically significant (p<0.05).

Conclusion: Negative effects of the pandemic were found in patients with heart failure as in other diseases. In this process, patients had high anxiety and worry scale scores and low quality of life scores.

References

Abraham, W. T., Fiuzat, M., Psotka, M. A., & O'Connor, C. M. (2020). Heart Failure Collaboratory Statement on Remote Monitoring and Social Distancing in the Landscape of COVID-19. JACC. Heart failure, 8(8), 692–694. https://doi.org/10.1016/j.jchf.2020.06.006

Akyay A. Endişe ve Anksiyete Ölçeği, Problemlere Karşı Olumsuz Tutum Ölçeği ve Bilişsel Kaçınma Ölçeği, Türkçe uyarlanması, geçerliliği ve güvenirliliği.: Üsküdar Üniversitesi; 2016.

Alkouri, O., Khader, Y., Hweidi, I. M., Gharaibeh, M. K., Jarrah, M., Hamdan, K. M., Al Marzouqi, A., & Khamaiseh, K. (2022). COVID-19 Fear and Anxiety among Patients with Chronic Heart Failure: A Cross Sectional Study. Journal of clinical medicine, 11(21), 6586. https://doi.org/10.3390/jcm11216586

Alqutob, R., Al Nsour, M., Tarawneh, M. R., Ajlouni, M., Khader, Y., Aqel, I., Kharabsheh, S., & Obeidat, N. (2020). COVID-19 Crisis in Jordan: Response, Scenarios, Strategies, and Recommendations. JMIR public health and surveillance, 6(3), e19332. https://doi.org/10.2196/19332

Bader, F., Manla, Y., Atallah, B., & Starling, R. C. (2021). Heart failure and COVID-19. Heart failure reviews, 26(1), 1–10. https://doi.org/10.1007/s10741-020-10008-2

Celano, C. M., Daunis, D. J., Lokko, H. N., Campbell, K. A., & Huffman, J. C. (2016). Anxiety Disorders and Cardiovascular Disease. Current psychiatry reports, 18(11), 101. https://doi.org/10.1007/s11920-016-0739-5

Çelik D, Türkmen AS. (2022). Kronik hastalığı olan bireylerin COVID-19 kaynaklı stres ve anksiyete düzeyleri: Karaman ili örneği. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi, 5(3), 286-297. DOI:10.38108/ouhcd.952646

Costa, L. L., Islam, M. S., Anowar, M. N., & Latif, M. A. (2020). Quality of life of chronic heart failure patients. Open Journal of Nursing, 10(9), 831-857.

Dekker, R. L., Lennie, T. A., Doering, L. V., Chung, M. L., Wu, J. R., & Moser, D. K. (2014). Coexisting anxiety and depressive symptoms in patients with heart failure. European journal of cardiovascular nursing, 13(2), 168–176. https://doi.org/10.1177/1474515113519520

Freedland KE, Rich MW, Carney RM. Improving Quality of Life in Heart Failure. Curr Cardiol Rep. 2021 Oct 1;23(11):159. doi: 10.1007/s11886-021-01588-y. PMID: 34599415.

Ghuloom, A. M., & Sanad, H. M. (2023). Perceived quality of life in patients with heart failure: a cross-sectional study among adults in Kingdom of Bahrain. Arab Gulf Journal of Scientific Research, 41(1), 67-76.

Hallas, C. N., Wray, J., Andreou, P., & Banner, N. R. (2011). Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart & lung, 40(2), 111-121.

Kumar A, Parrillo JE, Kumar A (2002) Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6(6):500

Lim, S.L., Woo, K.L., Lim, E. et al. Impact of COVID-19 on health-related quality of life in patients with cardiovascular disease: a multi-ethnic Asian study. Health Qual Life Outcomes 18, 387 (2020). https://doi.org/10.1186/s12955-020-01640-5

Luttik, M. L., Jaarsma, T., Veeger, N., & van Veldhuisen, D. J. (2006). Marital status, quality of life, and clinical outcome in patients with heart failure. Heart & lung : the journal of critical care, 35(1), 3–8. https://doi.org/10.1016/j.hrtlng.2005.08.001

Madjid, M., Safavi-Naeini, P., Solomon, S. D., & Vardeny, O. (2020). Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA cardiology, 5(7), 831–840. https://doi.org/10.1001/jamacardio.2020.1286

McIlvennan, C. K., Allen, L. A., Devore, A. D., Granger, C. B., Kaltenbach, L. A., & Granger, B. B. (2020). Changes in Care Delivery for Patients With Heart Failure During the COVID-19 Pandemic: Results of a Multicenter Survey. Journal of cardiac failure, 26(7), 635–636. https://doi.org/10.1016/j.cardfail.2020.05.019

Ng, T. M., & Toews, M. L. (2016). Impaired norepinephrine regulation of monocyte inflammatory cytokine balance in heart failure. World journal of cardiology, 8(10), 584–589. https://doi.org/10.4330/wjc.v8.i10.584

Ornell, F., Schuch, J. B., Sordi, A. O., & Kessler, F. H. P. (2020). "Pandemic fear" and COVID-19: mental health burden and strategies. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 42(3), 232–235. https://doi.org/10.1590/1516-4446-2020-0008

Salant P ve Don A. Dillman, How to Conduct Your Own Survey, John Wiley & Sons, Inc. Newyork, , s. 55, 1994.

Sankaranarayanan, R., Hartshorne-Evans, N., Redmond-Lyon, S., Wilson, J., Essa, H., Gray, A., Clayton, L., Barton, C., Ahmed, F. Z., Cunnington, C., Satchithananda, D. K., and Murphy, C. L. (2021) The impact of COVID-19 on the management of heart failure: a United Kingdom patient questionnaire study. ESC Heart Failure, 8: 1324– 1332.

The European Society for Cardiology. The European Society for Cardiology. ESC Guidance for the diagnosis and management of CV disease during the COVID-19 pandemic. 2020.

Tufan, A., Avanoğlu Güler, A., & Matucci-Cerinic, M. (2020). COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turkish journal of medical sciences, 50(SI-1), 620–632. https://doi.org/10.3906/sag-2004-168

Özden,Tok, Ö; Yılmaz, Y; Sakallı, Kani; A, İnce, Guliyev,E; Kılıckıran, Avcı, B; Yiğit, Z; (2020). Kalp yetersizliği hastalarında depresyon ve anksiyete. Pam Tıp Derg;15:619-626

Özmen, S., Özkan, O., Özer, Ö., Yanardağ, M. Z. (2021). Investigation of COVID-19 fear, well-being and life satisfaction in Turkish society. Social work in public health, 36(2), 164-177.

Uzunhasanoğlu Z. Minnesota Kalp Yetmezliği İle Yaşam Anketinin Türkçe Geçerlilik Ve Güvenilirliği (tez). Ankara: Ankara Üniversitesi Sağlık Bilimleri Enstitüsü; 2013.

Wu M, Shen L, Wang Q, Liu L, Lu S, Jin J, Dai Z, Shu Z. Anxiety and Depression Prevalence and Risk Factors Among Patients With Cardiovascular Diseases in Post-COVID-19 China. Front Public Health. 2022 Jan 4;9:758874. doi: 10.3389/fpubh.2021.758874.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42.

Zhang, J., Gilmour, S., Liu, Y., & Ota, E. (2020). Effect of health literacy on quality of life among patients with chronic heart failure in China. Quality of Life Research, 29(2), 453–461.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England), 395(10229), 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3

Published

2023-05-12

How to Cite

HİÇERİMEZ , A., ÖZKAN, A., AĞUSTOS, S., & SAYGILI ERİŞİR, N. (2023). Determination of Anxiety, Anxiety Level and Quality of Life of Heart Failure Patients in the COVID-19 Process. GEVHER NESIBE JOURNAL OF MEDICAL AND HEALTH SCIENCES, 8(2), 270–278. https://doi.org/10.5281/zenodo.7919355

Issue

Section

Articles